SEC23B and prostate cancer: In addition, SEC23B is shown to be a target of miR-130a and the latter was downregulated in prostate cancer 80, whereas miR-130a overexpression in prostate cancer cells reduced tumor cell proliferation and invasion capacity but induced apoptosis 80.